إعلان
إعلان
ANAB
AnaptysBio, Inc. Common Stock
44.61
USDبرعاية
+0.81
+1.86%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
44.63
+0.01
+0.03%
تقارير أرباح ANAB
النسبة الإيجابية المفاجئة
ANAB تفوق 22 من 36 آخر التقديرات.
61%
التقرير التالي
بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$94.66M
/$0.96
التغير الضمني من Q3 25 (Revenue/ EPS)
+24.03%
/+84.62%
التغير الضمني من Q4 24 (Revenue/ EPS)
+119.57%
/-233.33%
AnaptysBio, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, ANAB reported earnings of 0.52 USD per share (EPS) for Q3 25, beating the estimate of -1.48 USD, resulting in a 134.93% surprise. Revenue reached 76.32 مليون, compared to an expected 16.13 مليون, with a 373.23% difference. The market reacted with a +3.63% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 المحللين forecast an EPS of 0.96 USD, with revenue projected to reach 94.66 مليون USD, implying an زيادة of 84.62% EPS, and زيادة of 24.03% in Revenue from the last quarter.
الأسئلة الشائعة
What were AnaptysBio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, AnaptysBio, Inc. Common Stock reported EPS of $0.52, beating estimates by 134.93%, and revenue of $76.32M, 373.23% above expectations.
How did the market react to AnaptysBio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 3.63%, changed from $34.74 before the earnings release to $36.00 the day after.
When is AnaptysBio, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
What are the forecasts for AnaptysBio, Inc. Common Stock's next earnings report?
Based on 13
المحللين, AnaptysBio, Inc. Common Stock is expected to report EPS of $0.96 and revenue of $94.66M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان